SWM
RVMD icon

Spire Wealth Management’s Revolution Medicines RVMD Stock Holding History

Spire Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
+16,140
New +$2.36M 0.09% 198
2025
Q4 		– Sell
-105
Closed -$4.9K – 2453
2025
Q3 		$4.9K Hold
105
– – ﹤0.01% 1960
2025
Q2 		$3.86K Sell
105
-13
-11% -$499 ﹤0.01% 2023
2025
Q1 		$4.17K Hold
118
– – ﹤0.01% 2106
2024
Q4 		$5.16K Buy
118
+105
+808% +$5.3K ﹤0.01% 2036
2024
Q3 		$590 Hold
13
– – ﹤0.01% 2138
2024
Q2 		$505 Buy
+13
New +$486 ﹤0.01% 2195

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Spire Wealth Management's RVMD Position: Q2 2026 in Review

Spire Wealth Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 16,140 shares worth $3.02M. The stake represents 0.09% of the portfolio and ranks #198 among its holdings. This is a return to the name: Spire Wealth Management previously reported a position in RVMD as recently as Q3 2025.

Spire Wealth Management first reported a position in RVMD in Q2 2024 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Spire Wealth Management held 16,140 shares of Revolution Medicines worth $3.02M as of Q2 2026.
  • Revolution Medicines was a new Spire Wealth Management position in Q2 2026.
  • Revolution Medicines made up 0.09% of Spire Wealth Management's portfolio in Q2 2026, its #198 holding.
  • Spire Wealth Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.